SAYENS
Overview
SAYENS is a French technology transfer accelerator that invests in innovations from public research laboratories to facilitate their transfer to companies and startups in the Grand Est and Burgundy-Franche-Comté regions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EktaH | Feb 2022 | Seed | Lead |
| Oragen Therapeutics | Apr 2026 | Crowdfunding | Co-investor |
| Sintermat | Nov 2018 | Seed | Co-investor |
| Econick | Dec 2017 | Accelerator | Co-investor |
Key People
Salma Amensag
Cheffe De Projets Innovation Santé DM Health Technologies Innovations Portfolio Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SAYENS based?
SAYENS is headquartered in Dijon, France.
When was SAYENS founded?
SAYENS was founded in 2013.
How many portfolio companies does SAYENS have?
SAYENS has 4 portfolio companies in Caplight's dataset.
What are some companies in SAYENS's portfolio?
Portfolio companies visible on Caplight include EktaH, Oragen Therapeutics, Sintermat, Econick.
What was SAYENS's most recent investment shown here?
SAYENS's most recent investment in this portfolio sample was in Oragen Therapeutics in 2026.
What sectors does SAYENS focus on?
SAYENS focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability.
What company stages does SAYENS focus on?
SAYENS typically invests at the Early stage.
What is SAYENS's AUM?
SAYENS's assets under management are estimated between $64.8M and $64.8M.